Anti-DDX23 antibody
5
(1 Review)
|
(1 Publication)
Rabbit Polyclonal DDX23 antibody. Suitable for WB and reacts with Human, Mouse samples. Cited in 1 publication. Immunogen corresponding to Synthetic Peptide within Human DDX23.
View Alternative Names
Probable ATP-dependent RNA helicase DDX23, 100 kDa U5 snRNP-specific protein, DEAD box protein 23, PRP28 homolog, U5-100kD, DDX23
- WB
Unknown
Western blot - Anti-DDX23 antibody (AB70461)
All lanes:
Western blot - Anti-DDX23 antibody (ab70461) at 0.04 µg/mL
Lane 1:
HeLa whole cell lysate at 50 µg
Lane 2:
HeLa whole cell lysate at 15 µg
Lane 3:
HeLa whole cell lysate at 5 µg
Lane 4:
293T whole cell lysate at 50 µg
Lane 5:
NIH3T3 whole cell lysate at 50 µg
Predicted band size: 96 kDa
Observed band size: 200 kDa,70 kDa,96 kDa
false
Exposure time: 30s
- WB
CiteAb
Western blot - Anti-DDX23 antibody (AB70461)
DDX23 western blot using anti-DDX23 antibody ab70461. Publication image and figure legend from Cloutier, P., Poitras, C., et al., 2017, Nat Commun, PubMed 28561026.
ab70461 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab70461 please see the product overview.
ZNHIT2 and RUVBL2 regulate the composition of the U5 snRNP.(a) Workflow of triple SILAC experiments. (b) Expression assessment of various U5 snRNP subunits following treatment with siZNHIT2 or siRUVBL2. (c–f) Interpretation of the SILAC data on scatterplots. Intensity ratio of medium-labelled proteins over unlabelled proteins (M/L) on the X axis denotes IP enrichment. Intensity ratio of medium-labelled proteins over heavy-labelled proteins (M/H) on the Y axis represents experimental variations. Marked proteins in the upper right quadrant (X>1, Y>1) are proteins enriched in the IP that were less abundant following siRNA treatment. Position of the protein used for IP is shown in all experiments.
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
DEAD-box helicase 23 participates in the spliceosome complex important for pre-mRNA splicing a process that removes introns and joins exons to form mature messenger RNA. DDX23 acts during spliceosome assembly and the catalytic activation phase. Through its helicase activity it facilitates structural transitions within the spliceosome ensuring accurate splicing of pre-mRNA molecules. This function is essential for accurate gene expression and cellular function.
Pathways
DDX23 is involved in the spliceosomal pathway and related RNA processing pathways. Its role in pre-mRNA splicing links DDX23 to the regulation of gene expression impacting numerous downstream pathways. Within these pathways DDX23 interacts closely with other spliceosome-associated proteins like PRPF8 and SNRNP200. These interactions ensure the efficiency and regulation of the splicing process critical to cellular and physiological functions.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 8:15615 PubMed28561026
2017
Applications
WB
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com